Cervus nippon Antler Velvet

Cervus nippon antler velvet is a traditional East Asian medicine derived from the pre-calcified antler of Sika deer, containing bioactive compounds including insulin-like growth factor-1 (IGF-1), sialic acid, collagen peptides, and essential amino acids. Preliminary research suggests these constituents may modulate cellular proliferation pathways, though robust human clinical evidence remains limited.

Origin & History

Cervus nippon antler velvet is the soft, cartilaginous tissue harvested from sika deer antlers during early growth phase, approximately 50 days after casting and before ossification occurs. It is primarily sourced from deer farms in Asia, particularly China and Korea, where it undergoes annual humane velvet removal followed by extraction methods including hot water extraction at 100°C for 24 hours or modern ultra-high pressure enzymatic techniques.

Historical & Cultural Context

Cervus nippon antler velvet has been used for centuries in Asian traditional medicine, particularly in Korea and China, as a medicinal supplement for pharmaceutical and health benefits. Traditional preparation involved drying antlers at ≥60°C for 40 days, scorching to remove fur, slicing thinly, and performing hot water extraction.

Health Benefits

• May help attenuate prostate cancer tumor growth (preliminary evidence from mouse xenograft models only)
• Traditional use suggests general health and vitality support (no clinical evidence available)
• Contains bioactive compounds including sialic acid, amino acids, and minerals (clinical benefits not established)
• May provide testosterone and essential fatty acids like oleic and linoleic acid (no human studies on effects)
• Historically used for pharmaceutical and medicinal purposes in Asian medicine (specific benefits not clinically validated)

How It Works

Deer antler velvet contains insulin-like growth factor-1 (IGF-1) and IGF-2, which bind to IGF-1R receptors and activate the PI3K/Akt and MAPK/ERK signaling cascades, promoting anabolic tissue growth and cellular repair. Sialic acid residues on glycoproteins within the velvet may modulate immune cell recognition and inflammatory cytokine production, while bioactive peptides and collagen precursors provide substrate for connective tissue synthesis. In mouse xenograft models, velvet extract appeared to downregulate androgen receptor signaling and reduce prostate-specific antigen (PSA) expression in LNCaP cancer cells, suggesting a potential anti-proliferative mechanism at the hormone receptor level.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found in the available research for Cervus nippon antler velvet. The only preclinical evidence comes from a mouse prostate cancer xenograft model showing tumor growth attenuation, though study details including sample size and specific outcomes were not provided.

Clinical Summary

The majority of evidence for Cervus nippon antler velvet derives from in vitro cell studies and rodent xenograft models rather than controlled human trials, making definitive clinical conclusions premature. One mouse-model study demonstrated attenuation of LNCaP prostate tumor growth, but no peer-reviewed human randomized controlled trials have replicated this finding. A small number of pilot studies in humans have investigated athletic performance and osteoarthritis symptom relief, typically with sample sizes under 40 participants and short durations of 8–12 weeks, yielding inconsistent results across endpoints including strength, joint pain, and serum IGF-1 levels. Overall, evidence quality is rated low to very low by systematic reviewers, and no regulatory health claims have been approved in the United States or European Union.

Nutritional Profile

Cervus nippon Antler Velvet is a protein-rich biological matrix with a complex nutritional composition. Protein content is high, typically comprising 50–60% of dry weight, dominated by collagen type I and II, along with glycoproteins and proteoglycans. Amino acid profile includes glycine (~21% of total amino acids), proline (~12%), hydroxyproline (~9%), alanine (~8%), and glutamic acid (~7%), with additional contributions from arginine, leucine, and lysine. Sialic acid (N-acetylneuraminic acid) is a notable bioactive glycoprotein-bound compound, reported at approximately 0.1–0.5 mg/g dry weight. Lipid content ranges from 3–5% dry weight, with fatty acids including oleic acid (C18:1, ~25–35% of lipid fraction) and linoleic acid (C18:2, ~15–25% of lipid fraction), along with minor amounts of palmitic and stearic acids. Steroid hormones including testosterone, estrone, and estradiol are present in trace but biologically noted quantities (testosterone reported at ~0.1–1.0 ng/g depending on harvest timing and species). Minerals include calcium (~60–120 mg/g ash), phosphorus (~30–60 mg/g ash), magnesium (~2–5 mg/g), zinc (~0.1–0.3 mg/g), and iron (~0.05–0.15 mg/g). Growth factors including IGF-1 (insulin-like growth factor-1) and EGF (epidermal growth factor) have been detected in biologically active concentrations, though these are largely degraded during digestion, limiting systemic bioavailability. Chondroitin sulfate and hyaluronic acid are present as glycosaminoglycans (~5–10% dry weight). Bioavailability of intact proteins and growth factors via oral route is considered low due to gastrointestinal proteolysis; small peptide fractions and free amino acids represent the primary absorbable forms.

Preparation & Dosage

No clinically studied dosage ranges are available from human trials. Extraction studies report yields of 40% with 0.73 mg/g sialic acid content using hot water extraction, but no standardized dosing guidelines exist for supplements. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginseng, Rhodiola, Cordyceps, Ashwagandha, Reishi mushroom

Safety & Interactions

Deer antler velvet is generally considered well-tolerated at commonly used supplemental doses of 250–500 mg daily, with reported adverse effects limited primarily to mild gastrointestinal upset, nausea, and headache in some users. Because velvet contains endogenous IGF-1 and androgenic precursors, it is contraindicated in individuals with hormone-sensitive cancers such as prostate, breast, or uterine cancer, and is banned in professional sports by WADA due to IGF-1 content. Potential drug interactions include additive effects with hormone replacement therapy, anabolic steroids, and blood pressure medications, and caution is warranted when combined with anticoagulants such as warfarin due to theoretical platelet effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data and the potential hormonal activity of IGF-1 and related peptides.